Analysis of IL1RN gene polymorphisms in Spanish patients with inflammatory bowel disease;Estudio de polimorfismos del gen IL1RN en pacientes españoles con colitis ulcerosa

Medicina Clinica

Volumn 112, Issue 20, 1999, Pages 778-779

  Sarmiento, Rogelio González ^b   Araoz, Patricia ^c   Rodríguez, Raquel ^c   Oliveira, Antonio ^a   Blanco, Ignacio Fernández ^a   Rodriguez, Ángel Sánchez ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIALOGLYCOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; DRUG ANTAGONISM; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; SPAIN; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; SPAIN;

EID: 0033526470     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Parke M, Satsangi J, Jewell D. Mapping susceptibility loci in inflammatory bowel disease: why and how? Mol Med Today 1997; 3: 546-553.
2. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-404.
3. Seo M, Okada M, Yao T, Ueki M, Arima S, Ukuruma M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1986; 87: 971-976.
4. Propst A, Propst T, Herold M, Vogel W, Judmaier G. Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases. Eur J Gastroenterol Hepatol 1995; 7: 1.031-1.036.
5. Hyams JS, Fitzgerald JE, Wyzga N, Muller R, Treem WR, Justinich CJ et al. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease. J Pediatr Gastroenterol Nutrition 1995; 21: 419-425.
6. Toyoda H, Wabg SJ, Yang HY, Redford A, Magalarg D, Tyan D. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104: 741-748.
7. Hacker UT, Gomolka M, Keller E, Ergter A, Folwaczny C, Fricke H et al. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut 1997; 40: 623-627.
8. Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yoconang J et al. Significance of interleukin-1b and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997; 92: 1.164-1.169.
9. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 antagonist. Gastroenterology 1994; 106: 637-642.
10. Bioque G, Crusius JBA, Koutroubakis I, Bouma G, Kostensen PJ, Meuwissen SGM et al. Alleic polymorphism in IL-1b and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379-383